{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T08:50:33Z","timestamp":1791449433519,"version":"4.3.3"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T00:00:00Z","timestamp":1789084800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Minist\u00e8re de l\u2019Enseignement Sup\u00e9rieur et de la Recherche"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s13555-026-01914-8","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T16:05:45Z","timestamp":1789142745000},"page":"5229-5244","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A New Phototherapy Regimen Coupled with Oral Vitamin D Supplementation, for the Long-Term Control of Atopic Dermatitis: A French Multicenter, Randomized, Crossover, Pragmatic Trial"],"prefix":"10.1007","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6714-6643","authenticated-orcid":false,"given":"Catherine","family":"Droitcourt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Barbarot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Visseiche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annabel","family":"Maruani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Dinulescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laure","family":"Darrieux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Misery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Brenaut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ang\u00e8le","family":"Soria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie","family":"Vermersch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herv\u00e9","family":"Maillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Seneschal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Taieb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Chabbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henri","family":"Adamski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Dupuy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Oger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,11]]},"reference":[{"issue":"6","key":"1914_CR1","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1111\/all.13401","volume":"73","author":"S Barbarot","year":"2018","unstructured":"Barbarot S, Auziere S, Gadkari A, et al. Epidemiology of atopic dermatitis in adults: results from an international survey. Allergy. 2018;73(6):1284\u201393. https:\/\/doi.org\/10.1111\/all.13401.","journal-title":"Allergy"},{"issue":"5","key":"1914_CR2","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/S2213-2600(25)00003-7","volume":"13","author":"GBD 2021 Asthma and Allergic Diseases Collaborators","year":"2025","unstructured":"GBD 2021 Asthma and Allergic Diseases Collaborators. Global, regional, and national burden of asthma and atopic dermatitis, 1990-2021, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021. Lancet Respir Med. 2025;13(5):425\u201346. https:\/\/doi.org\/10.1016\/S2213-2600(25)00003-7.","journal-title":"Lancet Respir Med"},{"issue":"9","key":"1914_CR3","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1111\/jdv.20639","volume":"39","author":"A Wollenberg","year":"2025","unstructured":"Wollenberg A, Kinberger M, Arents B, et al. European guideline (EuroGuiDerm) on atopic eczema: living update. J Eur Acad Dermatol Venereol. 2025;39(9):1537\u201366. https:\/\/doi.org\/10.1111\/jdv.20639.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"1914_CR4","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.anai.2023.11.009","volume":"132","author":"DK Chu","year":"2023","unstructured":"AAAAI\/ACAAI JTF Atopic Dermatitis Guideline Panel, Chu DK, Schneider L, et al. Atopic dermatitis (eczema) guidelines: 2023 American Academy of Allergy, Asthma and Immunology\/American College of Allergy, Asthma and Immunology Joint Task Force on Practice Parameters GRADE- and Institute of Medicine-based recommendations. Ann Allergy Asthma Immunol. 2023;132(3):274\u2013312. https:\/\/doi.org\/10.1016\/j.anai.2023.11.009.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"3","key":"1914_CR5","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1111\/bjd.12645","volume":"170","author":"FM Garritsen","year":"2014","unstructured":"Garritsen FM, Brouwer MWD, Limpens J, Spuls PI. Photo(chemo)therapy in the management of atopic dermatitis: an updated systematic review with implications for practice and research. Br J Dermatol. 2014;170(3):501\u201313. https:\/\/doi.org\/10.1111\/bjd.12645.","journal-title":"Br J Dermatol"},{"issue":"7403","key":"1914_CR6","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.326.7403.1367","volume":"326","author":"J Berth-Jones","year":"2003","unstructured":"Berth-Jones J, Damstra RJ, Golsch S, et al. Twice weekly fluticasone propionate added to emollient maintenance treatment to reduce risk of relapse in atopic dermatitis: randomised, double blind, parallel group study. BMJ. 2003;326(7403):1367. https:\/\/doi.org\/10.1136\/bmj.326.7403.1367.","journal-title":"BMJ"},{"issue":"7","key":"1914_CR7","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1111\/j.1398-9995.2008.01683.x","volume":"63","author":"A Wollenberg","year":"2008","unstructured":"Wollenberg A, Reitamo S, Girolomoni G, et al. Proactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointment. Allergy. 2008;63(7):742\u201350.","journal-title":"Allergy"},{"issue":"6","key":"1914_CR8","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1016\/j.jaci.2013.12.1079","volume":"133","author":"TS Tang","year":"2014","unstructured":"Tang TS, Bieber T, Williams HC. Are the concepts of induction of remission and treatment of subclinical inflammation in atopic dermatitis clinically useful? J Allergy Clin Immunol. 2014;133(6):1615-1625.e1. https:\/\/doi.org\/10.1016\/j.jaci.2013.12.1079.","journal-title":"J Allergy Clin Immunol"},{"issue":"7","key":"1914_CR9","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1111\/all.16160","volume":"79","author":"E Vassilopoulou","year":"2024","unstructured":"Vassilopoulou E, Comotti A, Douladiris N, et al. A systematic review and meta-analysis of nutritional and dietary interventions in randomized controlled trials for skin symptoms in children with atopic dermatitis and without food allergy: an EAACI task force report. Allergy. 2024;79(7):1708\u201324. https:\/\/doi.org\/10.1111\/all.16160.","journal-title":"Allergy"},{"issue":"9","key":"1914_CR10","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1111\/jdv.20218","volume":"38","author":"C Droitcourt","year":"2024","unstructured":"Droitcourt C, Arellano J. Atopic dermatitis and vitamin D supplementation: the end of the story? J Eur Acad Dermatol Venereol. 2024;38(9):1677\u20138. https:\/\/doi.org\/10.1111\/jdv.20218.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"23","key":"1914_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/nu16234128","volume":"16","author":"AY Nielsen","year":"2024","unstructured":"Nielsen AY, H\u00f8j S, Thomsen SF, Meteran H. Vitamin D supplementation for treating atopic dermatitis in children and adults: a systematic review and meta-analysis. Nutrients. 2024;16(23):4128. https:\/\/doi.org\/10.3390\/nu16234128.","journal-title":"Nutrients"},{"issue":"5","key":"1914_CR12","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1056\/NEJMra1510059","volume":"375","author":"I Ford","year":"2016","unstructured":"Ford I, Norrie J. Pragmatic trials. N Engl J Med. 2016;375(5):454\u201363. https:\/\/doi.org\/10.1056\/NEJMra1510059.","journal-title":"N Engl J Med"},{"issue":"1","key":"1914_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-019-3276-9","volume":"20","author":"C Droitcourt","year":"2019","unstructured":"Droitcourt C, Barbarot S, Maruani A, et al. A new phototherapy regimen during winter as an add-on therapy, coupled with oral vitamin D supplementation, for the long-term control of atopic dermatitis: study protocol for a multicentre, randomized, crossover, pragmatic trial\u2014the PRADA trial. Trials. 2019;20(1):184. https:\/\/doi.org\/10.1186\/s13063-019-3276-9.","journal-title":"Trials"},{"issue":"10","key":"1914_CR14","doi-asserted-by":"publisher","DOI":"10.18637\/jss.v054.i10","volume":"54","author":"SM Kreidler","year":"2013","unstructured":"Kreidler SM, Muller KE, Grunwald GK, et al. GLIMMPSE: online power computation for linear models with and without a baseline covariate. J Stat Softw. 2013;54(10):i10. https:\/\/doi.org\/10.18637\/jss.v054.i10.","journal-title":"J Stat Softw"},{"issue":"1","key":"1914_CR15","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1111\/jdv.19494","volume":"38","author":"S Barbarot","year":"2024","unstructured":"Barbarot S, Aubert H, Stalder J-F, Roye S, Delarue A. The patient\u2010oriented scoring of atopic dermatitis and SCORAD in young children: new data on interpretability and clinical usefulness. Acad Dermatol Venereol. 2024;38(1):175\u201381. https:\/\/doi.org\/10.1111\/jdv.19494.","journal-title":"Acad Dermatol Venereol"},{"issue":"1","key":"1914_CR16","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1159\/000365390","volume":"230","author":"MKA Basra","year":"2015","unstructured":"Basra MKA, Salek MS, Camilleri L, Sturkey R, Finlay AY. Determining the minimal clinically important difference and responsiveness of the Dermatology Life Quality Index (DLQI): further data. Dermatology. 2015;230(1):27\u201333. https:\/\/doi.org\/10.1159\/000365390.","journal-title":"Dermatology"},{"key":"1914_CR17","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.19096","author":"P Schmid-Grendelmeier","year":"2023","unstructured":"Schmid-Grendelmeier P, RapelanoroRabenja F, Beshah AM, et al. How to integrate atopic dermatitis in the management of skin neglected tropical diseases in Sub-Saharan Africa? J Eur Acad Dermatol Venereol. 2023. https:\/\/doi.org\/10.1111\/jdv.19096.","journal-title":"J Eur Acad Dermatol Venereol."},{"issue":"5","key":"1914_CR18","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1111\/jdv.19723","volume":"38","author":"O Faye","year":"2024","unstructured":"Faye O, Flohr C, Kabashima K, et al. Atopic dermatitis: a global health perspective. J Eur Acad Dermatol Venereol. 2024;38(5):801\u201311. https:\/\/doi.org\/10.1111\/jdv.19723.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"1914_CR19","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1111\/j.1398-9995.2011.02755.x","volume":"67","author":"AA Benson","year":"2012","unstructured":"Benson AA, Toh JA, Vernon N, Jariwala SP. The role of vitamin D in the immunopathogenesis of allergic skin diseases. Allergy. 2012;67(3):296\u2013301. https:\/\/doi.org\/10.1111\/j.1398-9995.2011.02755.x.","journal-title":"Allergy"},{"issue":"1","key":"1914_CR20","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1111\/j.1365-2133.2008.08601.x","volume":"159","author":"R Sidbury","year":"2008","unstructured":"Sidbury R, Sullivan AF, Thadhani RI, Camargo CA. Randomized controlled trial of vitamin D supplementation for winter-related atopic dermatitis in Boston: a pilot study. Br J Dermatol. 2008;159(1):245\u20137. https:\/\/doi.org\/10.1111\/j.1365-2133.2008.08601.x.","journal-title":"Br J Dermatol"},{"issue":"4","key":"1914_CR21","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.jaci.2014.08.002","volume":"134","author":"CA Camargo","year":"2014","unstructured":"Camargo CA, Ganmaa D, Sidbury R, Erdenedelger K, Radnaakhand N, Khandsuren B. Randomized trial of vitamin D supplementation for winter-related atopic dermatitis in children. J Allergy Clin Immunol. 2014;134(4):831-835.e1. https:\/\/doi.org\/10.1016\/j.jaci.2014.08.002.","journal-title":"J Allergy Clin Immunol"},{"issue":"9","key":"1914_CR22","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1111\/jdv.19959","volume":"38","author":"A Borzutzky","year":"2024","unstructured":"Borzutzky A, Iturriaga C, P\u00e9rez\u2010Mateluna G, et al. Effect of weekly vitamin D supplementation on the severity of atopic dermatitis and type 2 immunity biomarkers in children: a randomized controlled trial. J Eur Acad Dermatol Venereol. 2024;38(9):1760\u20138. https:\/\/doi.org\/10.1111\/jdv.19959.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"6","key":"1914_CR23","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1111\/bjd.18959","volume":"183","author":"FM Vermeulen","year":"2020","unstructured":"Vermeulen FM, Gerbens LaA, Schmitt J, et al. The European TREatment of ATopic eczema (TREAT) Registry Taskforce survey: prescribing practices in Europe for phototherapy and systemic therapy in adult patients with moderate-to-severe atopic eczema. Br J Dermatol. 2020;183(6):1073\u201382. https:\/\/doi.org\/10.1111\/bjd.18959.","journal-title":"Br J Dermatol"},{"key":"1914_CR24","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013870.pub2","volume":"10","author":"AH Musters","year":"2021","unstructured":"Musters AH, Mashayekhi S, Harvey J, et al. Phototherapy for atopic eczema. Cochrane Database Syst Rev. 2021;10:CD013870. https:\/\/doi.org\/10.1002\/14651858.CD013870.pub2.","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"1914_CR25","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1001\/jamadermatol.2023.3849","volume":"159","author":"CM Boesjes","year":"2023","unstructured":"Boesjes CM, Van Der Gang LF, Bakker DS, et al. Dupilumab-associated lymphoid reactions in patients with atopic dermatitis. JAMA Dermatol. 2023;159(11):1240. https:\/\/doi.org\/10.1001\/jamadermatol.2023.3849.","journal-title":"JAMA Dermatol"},{"issue":"5","key":"1914_CR26","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1016\/j.jaci.2024.07.019","volume":"154","author":"SYC Tsai","year":"2024","unstructured":"Tsai SYC, Phipatanakul W, Hawryluk EB, Oyoshi MK, Schneider LC, Ma KSK. Comparative safety of oral Janus kinase inhibitors versus dupilumab in patients with atopic dermatitis: a population-based cohort study. J Allergy Clin Immunol. 2024;154(5):1195-1203.e3. https:\/\/doi.org\/10.1016\/j.jaci.2024.07.019.","journal-title":"J Allergy Clin Immunol"},{"issue":"14","key":"1914_CR27","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1056\/NEJMsm1605385","volume":"377","author":"MA Hern\u00e1n","year":"2017","unstructured":"Hern\u00e1n MA, Robins JM. Per-protocol analyses of pragmatic trials. N Engl J Med. 2017;377(14):1391\u20138. https:\/\/doi.org\/10.1056\/NEJMsm1605385.","journal-title":"N Engl J Med"},{"issue":"2","key":"1914_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.annder.2024.103272","volume":"151","author":"F Poizeau","year":"2024","unstructured":"Poizeau F, Maruani A, Staumont-Sall\u00e9 D, et al. Promoting clinical research in community-based practice: threats and opportunities. Ann Dermatol Venereol. 2024;151(2):103272. https:\/\/doi.org\/10.1016\/j.annder.2024.103272.","journal-title":"Ann Dermatol Venereol"},{"issue":"1","key":"1914_CR29","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1002\/jvc2.548","volume":"4","author":"J Stalder","year":"2025","unstructured":"Stalder J, Lio P, Sentenac F, et al. The international society of atopic dermatitis held a meeting in Gda\u0144sk to discuss the organization of care in atopic dermatitis. JEADV Clin Pract. 2025;4(1):335\u201344. https:\/\/doi.org\/10.1002\/jvc2.548.","journal-title":"JEADV Clin Pract"}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-026-01914-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-026-01914-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-026-01914-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T08:00:22Z","timestamp":1791446422000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13555-026-01914-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,11]]},"references-count":29,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["1914"],"URL":"https:\/\/doi.org\/10.1007\/s13555-026-01914-8","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,11]]},"assertion":[{"value":"11 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Catherine Droitcourt has received speaker honoraria from Sanofi-Genzyme, AbbVie, Novartis, Almirall, UCB-Pharma, and Eli Lilly and Co. S\u00e9bastien Barbarot is an investigator or speaker for Astrazeneca, Almirall, Sanofi-Genzyme, Abbvie, Galderma, Alexion, Novartis, Janssen, Leo-Pharma, Pfizer, Eli Lilly, UCB Pharma, and Incyte. Annabel Maruani has attended advisory board for Sanofi-Genzyme. Monica Dinulescu has received speaker honoraria or support for attending meetings from Astrazeneca, Almirall, Sanofi-Genzyme, Abbvie, Galderma, Novartis, Janssen, Leo-Pharma, Pfizer, Eli Lilly, UCB Pharma, Roche, BMS, Pierre Fabre, and MSD. Laure Darrieux has received speaker honoraria or support for attending meetings from Almirall, Abbvie, Lilly, Novartis, and Brothier. Laurent Misery has received speaker honoraria from Almirall, Galderma, Leo, Pfizer, and Sanofi, has attended advisory boards for Almirall, Galderma, Leo, Lilly, Pfizer, and Sanofi. Emilie Brenaut has received speaker honoraria from AbbVie, Lilly, has attended advisory boards for Sanofi-Genzyme, Leo Pharma, and Pfizer. Ang\u00e8le Soria has received speaker honoraria from Novartis, Abbvie, Lilly, LEO Pharma, Pfizer, Sanofi, and Bioprojet, has attended advisory boards for Novartis, Abbvie, Sanofi and LEO Pharma, and research grant from Sanofi. Annie Vermersch has received speaker honoraria or support for attending meetings from Almirall, Sanofi-Genzyme, Abbvie, Galderma, Novartis, Janssen, Leo-Pharma, Pfizer, Eli Lilly, UCB Pharma, Roche, BMS, Pierre Fabre, Incyte, and Galderma. Herv\u00e9 Maillard has received speaker honoraria or support for attending meetings from Almirall, Sanofi-Genzyme, Abbvie, Galderma, Novartis, Janssen, Leo-Pharma, Pfizer, Eli Lilly, UCB Pharma, Roche, BMS, Pierre Fabre, Incyte, and Urgo. Julien Seneschal is a consultant, investigator for AbbVie, Almirall, Bristol Myers Squibb, Eli Lilly, Leo Pharma, Pfizer, Pierre Fabre, Sanofi. Alain Taieb received speaker honoraria or research grant or support for attending meetings from Sanofi-Genzyme, Kyowa Kirin, Novartis, Lilly, Janssen, Arena Pharmaceutical, and Pierre Fabre. C\u00e9cile Chabbert has received speaker honoraria or support for attending meetings from Amgen, Leo, Sanofi-Genzyme, UCB-Pharma, and Almirall. Henri Adamski has received speaker honoraria or support for attending meetings from Kyowa Kirin, Novartis, Alexion Pharma, and Recordati Rare Diseases. Alain Dupuy: has attended advisory boards for Sanofi-Genzyme and have received support for attending meetings from AbbVie and UCB Pharma. Val\u00e9rie Visseiche and Emmanuel Oger have nothing to disclose.","order":1,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The protocol was approved on 18 August 2015 by the \u201cComit\u00e9 de protection des Personnes\u201d (authorization no. 6 \u2013 887) and received authorization from ANSM on 27 July 2015 (authorization no. 150603A-42). The study was conducted in compliance with French law no. 2004-806 of 9 August 2004 and with Good Clinical Practice and the Helsinki Declaration (Ethical Principles for Medical Research involving Human Subjects, Tokyo 2004). Participant consent was obtained for participation in this study.","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}